TNFRSF9 and lymphoma: IPA of differentially expressed genes in PTCL identified 3 Inhibited Pathways common to both Dnmt3a+/- and Dnmt3aΔ/Δ PTCL (Tec Kinase signaling, Type I Diabetes Mellitus Signaling, 4-1BB Signaling in T Lymphocytes) and 1 commonly Activated Pathways (Cyclins and Cell Cycle regulation) in Dnmt3aΔ/Δ and Dnmt3a+/- lymphomas (S4 Fig).